SAB Biotherapeutics Inc - Warrant — Financial Statistics (NASDAQ:SABSW)

Financials

Key stats

Total common shares outstanding 1.48 M4.3 M5.04 M9.23 M9.29 M —

Valuation ratios

Enterprise value ————— — Price to earnings ratio —-0.28—-0-0.02 -0.04 Price to sales ratio —0.08—0.050.53 4.44 Price to cash flow ratio —1.3—-0-0.02 -0.05 Price to book ratio —0.13—00.03 0.03 Enterprise value to EBITDA ratio ————— —

Profitability ratios

Return on assets % —-0.22-0.37-0.5-0.77 -0.48 Return on equity % —-0.44-0.6-0.74-1.31 -1.25 Return on invested capital % —-214.86-263.16-423.21-619.6 -527.59 Gross margin % —100100100100 400 Operating margin % —-22-120.97-1 700.56-3 244.87 -122.29 K EBITDA margin % ————— — Net margin % —-28.16-78.4-1 884.5-2 579.03 -43.82 K

Liquidity ratios

Quick ratio ————— — Current ratio 0.281.961.475.452.98 16.04 Inventory turnover ————— — Asset turnover —1.530.370.030.02 0

Solvency ratios

Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio —00.0200 -0.02 Long term debt to total equity ratio —00.0300 -0.03

Per share metrics

Operating cash flow per share —1.37-5.39-4.55-3.7 -2.81 EBIT per share ————— — EBITDA per share ————— — Total debt per share ————— — Cash per share —12.153.4610.242.25 5.66 Net current asset value per share —17.715.0810.672.57 6.78 Tangible book value per share —14.17.1410.382.8 8.52 Working capital per share —8.681.638.711.71 3.59 Book value per share —14.17.1410.382.8 8.52